Stemcells, Inc. Relocates Corporate Headquarters and U.S. Research Labs
News Jul 20, 2011
StemCells, Inc. has announced that it has relocated its corporate headquarters and U.S.-based research and development operations to 7707 Gateway Blvd, Newark, CA 94560, USA.
The new facilities comprise newly constructed, custom designed laboratory and office space, and will house the majority of the Company’s U.S. workforce. The Company’s new main telephone number is (510) 456-4000.
“This is a ‘win win’ situation for employees and shareholders alike,” said Martin McGlynn, President and CEO of StemCells.
McGlynn continued, “Not only are we providing our scientists with modern, state of the art, R&D facilities designed to foster their ground breaking work, but by moving to the Pacific Research Center in Newark, we are significantly reducing the Company’s annual facility lease and operating expenses.”
StemCells’ other facilities in Cambridge, U.K., where the Company researches, develops and manufactures its SC Proven® line of media and reagent products, and in Mountain View, California, are not affected by this move.
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019